The Administrative Core (AC) exists to promote the vision of the Ponce Health Sciences University- Moffitt Cancer Center (PHSU-MCC) Partnership, which is to reduce health disparities in a variety of different ways, ultimately resulting in improved cancer treatments and precision medicine approaches best suited for the Puerto Rico and Florida Hispanic populations. The AC plays a significant role, serving as the functional infrastructure of the Partnership, promoting innovative cancer research, outreach and biobanking toward an underserved population, and research education of under-represented individuals. Specifically, it provides oversight, organization, and ongoing evaluation for the scientific and administrative aspects of the Partnership. Such oversight includes but is not limited to day-to-day administrative and financial oversight, coordination of activities, and logistical support. Administrative and coordinating activities occur at both institutions, with continuous communications being one of the principal responsibilities of the AC. In the renewal, the AC will retain a composition/configuration similar to that in the current Partnership. This structure is highly effective in providing scientific and administrative oversight while promoting collaboration among the multiple components. For the competitive renewal, the Specific Aims of the AC are to: 1) Provide the functional infrastructure of the Partnership in terms of innovation, direction, leadership, and fiscal/administrative support for the individual scientific projects and cores, 2) Facilitate communications at all levels, 3) Set expectations, provide support, and monitor the productivity of the Partnership?s projects and cores.
| Jusino, Shirley; Fernández-Padín, Fabiola M; Saavedra, Harold I (2018) Centrosome aberrations and chromosome instability contribute to tumorigenesis and intra-tumor heterogeneity. J Cancer Metastasis Treat 4: |
| King, Jamie L; Zhang, Baotong; Li, Yixiang et al. (2018) TTK promotes mesenchymal signaling via multiple mechanisms in triple negative breast cancer. Oncogenesis 7:69 |
| Bonilla-Valentín, Fernando Javier; Cerra, Javier; Cáceres-Perkins, William et al. (2018) Case Report of IgM Multiple Myeloma: Diagnosing a Rare Hematologic Entity. Cancer Control 25:1073274817744448 |
| Pérez-Morales, Jaileene; Núñez-Marrero, Angel; Santiago-Cardona, Pedro G (2018) Immunohistochemical Detection of Retinoblastoma Protein Phosphorylation in Human Tumor Samples. Methods Mol Biol 1726:77-84 |
| Dutil, Julie; Godoy, Lenin; Rivera-Lugo, Rafael et al. (2018) No Evidence for the Pathogenicity of the BRCA2 c.6937?+?594T>G Deep Intronic Variant: A Case-Control Analysis. Genet Test Mol Biomarkers 22:85-89 |
| Reverón, Dayana; López, Christian; Gutiérrez, Sylvia et al. (2018) Frequency of Mismatch Repair Protein Deficiency in a Puerto Rican Population with Colonic Adenoma and Adenocarcinoma. Cancer Genomics Proteomics 15:265-271 |
| Gonçalves, Vânia; Hudson, Janella; Canavarro, Maria Cristina et al. (2018) Childbearing across borders: Fertility and parenthood attitudes and decisions among breast cancer survivors in USA and Portugal. Breast 40:16-22 |
| Diaz-Zabala, Hector J; Ortiz, Ana P; Garland, Lisa et al. (2018) A Recurrent BRCA2 Mutation Explains the Majority of Hereditary Breast and Ovarian Cancer Syndrome Cases in Puerto Rico. Cancers (Basel) 10: |
| Rodríguez-López, Joshua L; Toro-Bahamonde, Alia M; Santiago-Méndez, Roberto J et al. (2018) An Unusual Case of Colorectal Adenocarcinoma Presenting as an Anterior Mediastinal Mass. Clin Colorectal Cancer 17:e115-e119 |
| Lee, Miyoung; Gudas, Lorraine J; Saavedra, Harold I (2018) Detection of E2F-DNA Complexes Using Chromatin Immunoprecipitation Assays. Methods Mol Biol 1726:143-151 |
Showing the most recent 10 out of 62 publications
